Drugs - Drugs Xagena

Drugs

Home Page

Xagena Medicine

Xagena.net

Antibiotics: FDA has restricted use of Telithromycin

Anemia related to chronic kidney disease: Mircera approved in Europe

Risk of osteonecrosis of the jaw for patients with underlying malignant condition treated with iv bisphosphonates

Abilify may cause neuroleptic malignant syndrome

Avandia linked to parotid gland enlargement

Deferasirox may cause acute renal failure and cytopenias

Pulmonary arterial hypertension: FDA has approved Ambrisentan

Avandia seems to be associated with risk of myocardial infarction and death from cardiovascular causes

Bevacizumab associated with tracheoesophageal fistula

Increased blood concentrations of Zanaflex with concomitant use of CYP1A2 inhibitors

Impetigo: FDA has approved Retapamulin ointment

United States: Novartis has agreed to stop selling Tegaserod

Long-term treatment with Rosiglitazone for type 2 diabetes linked to increased incidence of fractures in female patients

Phenylephrine: further study to demonstrate efficacy and safety

Lavender and tea tree oils may cause breast growth in boys

Allogeneic stem-cell transplant: a reformulation of Beclomethasone reduces mortality

Long-term opioids use for back pain may be ineffective and lead to abuse

Hip fractures: benzodiazepines are not associated

Long-term treatment with Actos: increased incidence of fractures in women

Post-myocardial infarction: improved adherence to statins and beta-blockers associated with longer survival

Ibuprofen interferes with antiplatelet activity of low dose Acetylsalicylic acid

Post-myocardial infarction: risk of death linked to COX-2 inhibitors and non-selective NSAIDs

Acne: link between Accutane and depression

Rimonabant, a obesity drug: loss of a few kilos, many questions

FDA has approved Vorinostat for cutaneous T-cell lymphoma

FDA: Risperidone approved for irritability associated with autism

Europe: Sprycel for treatment-resistant chronic myeloid leukaemia and Ph+ acute lymphoblastic leukaemia

Celecoxib for juvenile rheumatoid arthritis, FDA approved

FDA has revised labeling of Trasylol, a drug for reducing bleeding and the need for blood transfusions

FDA has approved Paliperidone for schizophrenia

Next Pages 1 2 3 4 5 6 [7] 8 9 10 »

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions